Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

CEA Antikörper

Dieses Maus Monoklonal-Antikörper erkennt spezifisch CEA in FACS, IHC (p) und IF. Er zeigt eine Reaktivität gegenüber Human.
Produktnummer ABIN3026753

Kurzübersicht für CEA Antikörper (ABIN3026753)

Target

Alle CEA Antikörper anzeigen
CEA (Carcinoembryonic Antigen Gene Family (CEA))

Reaktivität

  • 156
  • 11
  • 4
  • 4
  • 1
Human

Wirt

  • 108
  • 59
  • 3
  • 1
  • 1
Maus

Klonalität

  • 129
  • 38
  • 4
Monoklonal

Konjugat

  • 68
  • 17
  • 9
  • 6
  • 6
  • 5
  • 5
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
Dieser CEA Antikörper ist unkonjugiert

Applikation

  • 70
  • 55
  • 39
  • 31
  • 30
  • 27
  • 23
  • 18
  • 13
  • 13
  • 13
  • 11
  • 5
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
Flow Cytometry (FACS), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunofluorescence (IF)

Klon

CEA-Cocktail
  • Produktmerkmale

    This antibody recognizes proteins of 80-200 kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70 % are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix.

    Aufreinigung

    Protein G affinity chromatography

    Immunogen

    Recombinant full-length human protein was used as the immunogen for the pan-CEA antibody cocktail.

    Isotyp

    IgG
  • Applikationshinweise

    Optimal dilution of the pan CEA antibody to be determined by the researcher.

    1. Staining of formalin-fixed tissues requires boiling tissue sections in 10  mM Citrate buffer,  pH 6.0, for 10-20 min followed by cooling at RT for 20 minutes
    2. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min.\. Flow Cytometry: 0.5-1 μg/million cells in 0.1ml,Immunofluorescence: 0.5-1 μg/mL,Immunohistochemistry (FFPE): 0.5-1 μg/mL for 30 min at RT (1),Prediluted format : incubate for 30 min at RT (2)

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Konzentration

    1 mg/mL

    Buffer

    1 mg/mL in 1X PBS, BSA free, sodium azide free

    Konservierungsmittel

    Azide free

    Lagerung

    4 °C,-20 °C

    Informationen zur Lagerung

    Store the pan-CEA antibody cocktail at 2-8°C (with azide) or aliquot and store at -20°C or colder (without azide).
  • Target

    CEA (Carcinoembryonic Antigen Gene Family (CEA))

    Andere Bezeichnung

    Pan-CEA

    Hintergrund

    This antibody recognizes proteins of 80-200  kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70 % are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix.
Sie sind hier:
Chat with us!